March 23rd, 2017
In May 2017, a federal judge will determine whether a settlement of a false advertising class-action lawsuit against BrainStrong will be granted final approval. The complaint, which was originally filed in 2012 and amended in 2014, alleges that i-Health Inc. markets BrainStrong dietary supplements with DHA algal oil – including BrainStrong Toddler, BrainStrong Kids, and
July 11th, 2016
May 2015: The named plaintiffs voluntarily dismissed this action . The reasons have not been disclosed. October 2014: Another class-action lawsuit was filed against Bayer Healthcare for allegedly falsely advertising Flintstone Healthy Brain Support, a dietary supplement containing Omega-3 DHA, as supporting healthy brain function without scientific evidence to support such claim. (Kaplan et al
June 7th, 2016
TINA.org finds that the marketing of Algal-900 DHA violates FTC order.
April 11th, 2016
“Light Up Your Drained Brain” claims challenged.
January 19th, 2016
Don’t let these better brain claims go to your head.
July 21st, 2015
U.S. Senators question FDA, retailers about supplements.
December 8th, 2014
In December 2014, a class-action lawsuit was filed against Bayer for allegedly falsely advertising the Flintstones Healthy Brain Support supplement (a gummy, chewable supplement with DHA) as able to “Support Healthy Brain Function” without scientific evidence to support such claims. (Gershman et al v. Bayer Healthcare, LLC, Case No. 14-cv-05332, N. D. CA.). For more
October 15th, 2014
December 2014: This action was voluntarily dismissed . The reasons have not been disclosed. October 2014: A class-action lawsuit was filed against Bayer Healthcare for allegedly falsely advertising Flintstones Healthy Brain Support, a gummy-chewable dietary supplement containing DHA. Specifically, plaintiffs allege that the company misleadingly represents that taking the supplement supports “healthy brain function” without
January 6th, 2014
They don’t exist, warns FDA.
April 17th, 2017
March 2017: A federal judge granted plaintiff’s motion for class certification. To read the court decision, click here. October 2016: A class-action lawsuit was filed against Costco and NBTY for allegedly falsely representing that TruNature Ginkgo Biloba with Vinpocetine “supports alertness & memory” and “help[s] with mental clarity and memory” when, in reality, the supplement
March 31st, 2017
Supplement maker’s silence spells referral of cognitive claims to the FTC.
March 27th, 2017
How we can protect ourselves from the $40-50 billion supplement industry amid a shrinking government?
March 16th, 2017
In February 2017, a class-action lawsuit was filed against Quincy Bioscience for allegedly deceptively marketing Prevagen dietary supplements as clinically shown to improve memory and provide other cognitive benefits when such claims are false. (Karathanos et al v. Quincy Bioscience Holding Company, Inc. et al, Case No. 17-cv-1091, E. D. NY.) For more information about
March 6th, 2017
National Consumer Protection Week is a good time to bring attention to this bill.
February 24th, 2017
Claims about efficacy of supplements and undisclosed paid endorsers at issue.
February 13th, 2017
February 2017: Quincy Bioscience moved for an order staying the proceedings in this action pending the resolution of the lawsuit filed against it by the Federal Trade Commission and New York Attorney General in January 2017 (FTC et al v. Quincy Bioscience Holding Co., Inc. et al.). January 2015: A class-action lawsuit was filed against
February 9th, 2017
In February 2017, a class-action lawsuit was filed against Quincy Bioscience for allegedly falsely representing that Prevagen supplements improve memory and provide cognitive benefits, and that the benefits of Prevagen are clinically proven when such claims are not true and without adequate support to make them. (Vanderwerff et al v. Quincy Bioscience Holding Company, Inc.
February 6th, 2017
TINA.org investigation finds more than a dozen companies in good standing with the BBB following an FTC action.
January 10th, 2017
A false advertising class-action lawsuit against Quincy Bioscience was dismissed in June 2016. The complaint, which was originally filed in state court in March 2015 and transferred to federal court in September 2015, alleged that the company advertises the products as “Clinically Tested” to “Improve Memory” by 7.5% within 8 days, 10% within 30 days,
January 9th, 2017
Five things you should know about the FTC, New York lawsuit against Prevagen.